The primary aim of supportive care in patients with malignant gliomas is accurate symptom control in order to optimize quality of life. The palliative approach should be considered from the beginning of treatment, due to the intractable and incurable character of the disease. Neurological signs and symptoms have to be investigated clinically, as well as neuroradiologically in order to evaluate treatment response and to provide adequate supportive care.